Abstract
Tricuspid regurgitation (TR) is a severe condition and is highly prevalent, has poor outcomes which are associated with high mortality in all clinical contexts. TR is prominently undertreated by surgery. TR is often detected late in the patients who present with right-sided heart failure. To deal with these issues, numerous transcatheter interventional devices for tricuspid valve have been developed. There is a complex pathway from daily clinical practice of TR diagnosis, adequate assessment of TR severity, appropriate access to therapeutic opportunities, following-up patients and their outcomes… to the conduction of well-designed clinical trials. This review summarizes the main points and imaging methods important to TR diagnosis, quantification, classification, risk stratification, intervention-monitoring, and outcomes evaluation, especially of right-sided function, and to the development and conduction of clinical trials for both interventional and surgical groups
